Alleviant Medical Receives Breakthrough Device Designation From FDA for Transcatheter Technology
/
DateJan 25 2021
The technology offers a no-implant interatrial shunt therapy for patients suffering from heart failure with preserved (HFpEF) and mid-range ejection fraction (HFmrEF) who remain symptomatic despite optimal guideline directed medical therapy. Read More →
















